Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ATG-031 by Antengene for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase...
Data Insights
ATG-031 by Antengene for Solid Tumor: Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...